文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

早期动态动脉血气轨迹识别急性低氧性呼吸衰竭的临床表型并预测结局:一项回顾性队列研究

Early dynamic arterial blood gas trajectories to identify clinical phenotypes and predict outcomes in acute hypoxemic respiratory failure: A retrospective cohort study.
PubMed 文献 · Am J Emerg Med · 2026-08-14
一句话结论基于ICU前24小时动态动脉血气轨迹聚类可识别三种AHRF表型,其中代谢型28天死亡风险显著更高(HR 1.38),稳定型预后较好。

本研究为单中心回顾性队列,纳入2020年1月至2025年6月四川省人民医院ICU的2793例急性低氧性呼吸衰竭患者,利用入ICU后24小时内多次动脉血气参数(PaO2/FiO2、PaCO2、pH、HCO₃-、乳酸)构建纵向轨迹特征,采用无监督K-means聚类识别出三种表型:呼吸型(n=882)、代谢型(n=683)、稳定型(n=1228)。代谢型表现为持续高乳酸血症和严重氧合障碍,ICU死亡率18%、28天死亡率24%、住院死亡率18%,均为三组最高;Kaplan-Meier分析显示其28天总生存显著劣于其他两组(log-rank P<0.001)。多因素Cox回归校正年龄、性别、APACHE II评分、机械通气、24小时血气采样频率及常规实验室指标后,代谢型相比呼吸型仍独立增加28天死亡风险(HR=1.38,95%CI 1.12-1.70,P=0.003);稳定型显示死亡风险降低趋势(HR=0.83,95%CI 0.67-1.00,P=0.104)。将动态表型加入基线预测模型使28天死亡预测C-index从0.657提升至0.671(P<0.001)。该动态亚表型框架可为传统静态评分系统提供增量预后信息。

要点

  • 在AHRF患者中,入ICU后24小时内基于PaO2/FiO2、PaCO2、pH、HCO₃-和乳酸的动态血气轨迹可聚类为呼吸型、代谢型、稳定型三种表型。
  • 代谢型(n=683)特征为持续高乳酸血症和严重氧合障碍,28天死亡率24%,为三组最高,且独立增加28天死亡风险(HR=1.38,95%CI 1.12-1.70,P=0.003,对比呼吸型)。
  • 稳定型(n=1228)28天死亡风险呈降低趋势(HR=0.83,95%CI 0.67-1.00,P=0.104,对比呼吸型),预后相对较好。
  • 24小时动脉血气采样频率本身与死亡率无独立关联(HR=1.01,95%CI 0.94-1.10,P=0.773),校正后表型关联仍稳健。
  • 将动态表型加入基线模型使28天死亡预测C-index从0.657提升至0.671(P<0.001),提供超越APACHE II评分的增量预后信息。

适用人群与场景

  • 纳入2020年1月至2025年6月四川省人民医院ICU收治的急性低氧性呼吸衰竭(AHRF)患者,共2793例。
  • 研究场景为ICU,利用入ICU后第一个24小时内的动脉血气参数。

诊断标准与关键阈值

  • 原文未提及AHRF的诊断标准或血气阈值。
  • 表型基于入ICU后24小时内多次动脉血气参数(PaO2/FiO2、PaCO2、pH、HCO₃-、乳酸)的纵向轨迹特征,采用无监督K-means聚类识别,原文未给出具体聚类参数或界值。

处置流程与药物剂量

  • 原文未提及基于表型的特定治疗干预或药物剂量方案。

红旗征与不能漏的情况

  • 代谢型表型(持续高乳酸血症和严重氧合障碍)与显著更高的28天死亡风险独立相关(HR=1.38,95%CI 1.12-1.70),需警惕。
  • 原文未提及需要立刻处理或不能漏诊的具体红旗征及处理措施。

研究设计与关键结果

  • 研究类型:单中心回顾性队列研究;样本量2793例;单中心(四川省人民医院ICU)。
  • 人群:急性低氧性呼吸衰竭患者;干预:无(观察性研究);对照:不同表型间比较。
  • 主要终点:28天死亡率。代谢型(n=683)28天死亡率24%,ICU死亡率18%,住院死亡率18%,均为三组最高;Kaplan-Meier分析显示代谢型28天总生存显著劣于其他两组(log-rank P<0.001)。
  • 多因素Cox回归校正年龄、性别、APACHE II评分、机械通气、24小时血气采样频率及WBC、肌酐、AST、ALT后,代谢型相比呼吸型独立增加28天死亡风险(HR=1.38,95%CI 1.12-1.70,P=0.003);稳定型显示死亡风险降低趋势(HR=0.83,95%CI 0.67-1.00,P=0.104)。
  • 24小时血气采样频率与死亡率无独立关联(HR=1.01,95%CI 0.94-1.10,P=0.773)。
  • 将动态表型加入基线预测模型使28天死亡预测C-index从0.657提升至0.671(P<0.001)。

证据类型、等级与局限

  • 证据类型:单中心回顾性队列研究。
  • 局限:单中心、回顾性设计、样本来自单一医院,原文未提及外部验证;表型为数据驱动聚类,需前瞻性验证。

对床旁实践的改变

  • 对于AHRF患者,在入ICU后24小时内动态监测动脉血气(PaO2/FiO2、PaCO2、pH、HCO₃-、乳酸)有助于早期识别代谢型表型,该表型28天死亡风险显著更高(HR 1.38),可提示临床加强关注。
  • 稳定型表型预后相对较好(28天死亡风险HR 0.83,趋势),可能有助于避免过度治疗,但原文未提供具体干预措施。
  • 动态血气表型可提供超越APACHE II评分的增量预后信息(C-index从0.657升至0.671),但提升幅度有限。
  • 该研究为单中心回顾性,表型聚类框架尚未在前瞻性研究中验证,不能直接作为治疗决策依据。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Acute hypoxemic respiratory failure (AHRF) is a critical syndrome frequently encountered in intensive care, characterized by substantial pathophysiological heterogeneity and poor clinical outcomes. Traditional static risk assessments based on a single time point struggle to capture the dynamic physiological responses to early interventions, thereby limiting precise risk stratification. This study aimed to identify distinct clinical phenotypes in patients with AHRF using dynamic arterial blood gas (ABG) trajectories during early intensive care unit (ICU) stay and evaluate their association with 28-day mortality.

METHODS: This was a single-center retrospective cohort study including patients with AHRF admitted to the ICU of Sichuan Provincial People's Hospital between January 2020 and June 2025. Multiple ABG parameters within the first 24 h of ICU admission-including PaO2/FiO2, PaCO2, pH, HCO₃-, and lactate-were extracted to construct longitudinal trajectory features. Unsupervised K-means clustering was performed to identify dynamic clinical phenotypes. Kaplan-Meier survival analysis and multivariable Cox proportional hazards regression models (adjusted for iatrogenic confounding variables such as the 24-h ABG sampling frequency) were utilized to assess the association between phenotypes and 28-day survival outcomes. The incremental predictive value of the phenotypes relative to the APACHE II score was evaluated using the concordance index (C-index).

RESULTS: A total of 2793 patients with AHRF were included and classified into three distinct clinical phenotypes with unique physiological evolution patterns: Phenotype 1 (Respiratory, n = 882), Phenotype 2 (Metabolic, n = 683), and Phenotype 3 (Stable, n = 1228). Phenotype 2 was characterized by persistent hyperlactatemia and profound oxygenation impairment, exhibiting the highest ICU mortality (18%), 28-day mortality (24%), and hospital mortality (18%) among the three groups. Kaplan-Meier analysis indicated that the 28-day overall survival for Phenotype 2 was significantly worse than that of the other two groups (log-rank P < 0.001). Multivariable Cox regression demonstrated that after adjusting for age, gender, APACHE II score, mechanical ventilation, 24-h ABG sampling frequency, and routine laboratory biomarkers (WBC, creatinine, AST, ALT), Phenotype 2 (Metabolic)remained independently associated with an increased 28-day mortality risk compared with Phenotype 1 (Respiratory, HR = 1.38, 95% CI: 1.12-1.70, P = 0.003). The ABG sampling frequency itself showed no independent association with mortality (HR = 1.01, 95% CI: 0.94-1.10, P = 0.773). Phenotype 3 (Stable) showed a trend toward reduced mortality risk (HR = 0.83, 95% CI: 0.67-1.00, P = 0.104). Integrating dynamic phenotypes into the baseline prediction model significantly improved the C-index for predicting 28-day mortality from 0.657 to 0.671 (P < 0.001).

CONCLUSIONS: Unsupervised clustering based on early dynamic ABG trajectories effectively identifies three distinct clinical phenotypes with divergent prognostic features in patients with AHRF. Phenotype 2 (Metabolic) denotes a substantially higher 28-day mortality risk, whereas Phenotype 3 (Stable) confers a relatively favorable outcome. This dynamic subphenotyping framework provides valuable incremental prognostic information beyond traditional static scoring systems.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Zhang Y, Wu X, Yang Y, et al. Early dynamic arterial blood gas trajectories to identify clinical phenotypes and predict outcomes in acute hypoxemic respiratory failure: A retrospective cohort study. Am J Emerg Med. 2026. PMID: 42636614. doi:10.1016/j.ajem.2026.08.021

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。